Browsing byAuthorAnker, SD
Showing results 1 to 4 of 4
| Issue Date | Title | Author(s) |
| 2024-06 | Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series. | Yule, MS; Thompson, J; Leesahatsawat, K; Sousa, MS; Anker, SD; Arends, J; Balstad, TR; Brown, LR; Bye, A; Dajani, O; Fallon, M; Hjermstad, MJ; Jakobsen, G; McDonald, J; McGovern, J; Roeland, EJ; Sayers, J; Skipworth, RJE; Ottestad, IO; Philips, I; Simpson, MR; Solheim, TS; Vagnildhaug, OM; McMillan, D; Laird, BJA; Dolan, RD; Cancer Cachexia Endpoints Working Group, |
| 2018-09 | PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study. | Laufs, U; Griese-Mammen, N; Krueger, K; Wachter, A; Anker, SD; Koehler, F; Rettig-Ewen, V; Botermann, L; Strauch, D; Trenk, D; Böhm, M; Schulz, M |
| 2023-10 | Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series. | McDonald, J; Sayers, J; Anker, SD; Arends, J; Balstad, TR; Baracos, V; Brown, L; Bye, A; Dajani, O; Dolan, R; Fallon, MT; Fraser, E; Griel, C; Grzyb, A; Hjermstad, M; Jamal-Hanjani, M; Jakobsen, G; Kaasa, S; McMillan, D; Maddocks, M; Philips, I; Ottestad, IO; Reid, KF; Sousa, MS; Simpson, MR; Vagnildhaug, OM; Skipworth, RJE; Solheim, TS; Laird, BJA; Cancer Cachexia Endpoints Working Group, |
| 2020-07-23 | The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial. | Schulz, M; Griese-Mammen, N; Schumacher, PM; Anker, SD; Koehler, F; Ruckes, C; Rettig-Ewen, V; Wachter, R; Trenk, D; Böhm, M; Laufs, U |
